주식/증권
➡️ 중립
How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers
요약
Pfizer said Sunday its Braftovi-tied regimen nearly doubled the length of time colon cancer patients lived without getting sicker.